BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.1845
-0.0162 (-8.07%)
At close: Feb 11, 2026, 4:00 PM EST
0.1930
+0.0085 (4.61%)
After-hours: Feb 11, 2026, 6:10 PM EST
BioAtla Market Cap
BioAtla has a market cap or net worth of $11.82 million as of February 11, 2026. Its market cap has decreased by -58.52% in one year.
Market Cap
11.82M
Enterprise Value
9.68M
1-Year Change
-58.52%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $11.82M, a decrease of -97.95%. That is a compound annual growth rate of -52.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 12.85M | -61.65% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 12.58M |
| GT Biopharma | 12.55M |
| BioCardia | 12.52M |
| OSR Holdings | 12.37M |
| CytoMed Therapeutics | 12.00M |
| Imunon | 11.63M |
| Longeveron | 11.55M |
| KALA BIO | 11.29M |